Alphatec Holdings, Inc.

ATEC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $764.2M $611.6M $482.3M $350.9M $243.2M $144.9M $113.4M $91.7M
Cost of Revenue $232.3M $187.3M $172.1M $117.8M $85.5M $42.4M $35.8M $28.5M
Gross Profit $531.9M $424.3M $310.2M $233.1M $157.8M $102.5M $77.6M $63.2M
Gross Margin 69.6% 69.4% 64.3% 66.4% 64.9% 70.8% 68.4% 69.0%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $498.5M $450.2M $374.1M $300.0M $229.3M $129.2M $101.7M $72.6M
Operating Income $-82.1M $-136.2M $-173.4M $-147.0M $-128.1M $-58.9M $-47.3M $-22.4M
Operating Margin -10.7% -22.3% -36.0% -41.9% -52.7% -40.6% -41.7% -24.5%
Interest Expense $45.9M $24.9M $16.6M $5.5M $7.1M $12.4M $9.9M —
Pretax Income $-143.4M $-162.1M $-186.9M $-152.0M $-144.2M $-78.8M $-57.1M $-30.2M
Income Tax Expense $-45.0K $50.0K $-277.0K $-716.0K $-1.1M $145.0K $-239.0K $-1.4M
Net Income $-143.4M $-162.1M $-186.6M $-151.3M $-143.0M $-79.0M $-57.0M $-29.0M
Net Margin -18.8% -26.5% -38.7% -43.1% -58.8% -54.5% -50.3% -31.6%
EPS (Basic) $-0.96 $-1.13 $-1.54 $-1.46 $-1.49 $-1.18 $-1.09 $-1.20
EPS (Diluted) $-0.96 $-1.13 $-1.54 $-1.46 $-1.49 $-1.18 $-1.09 $-1.20
Shares Outstanding (Basic) 150.1M 142.9M 121.2M 103.4M 96.2M 67.0M 61.4M 35.3M
Shares Outstanding (Diluted) 150.1M 142.9M 121.2M 103.4M 96.2M 67.0M 61.4M 35.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →